Experimental and Therapeutic Medicine · 2016 · 19 citations · 49 references
Life SciencesInfectious DiseasesMicrobiologyAntimicrobial ResistanceBacteriologyMedical MicrobiologyAntibacterial ResistanceAntibiotic ResistanceBeta-lactam ResistanceCarbapenem ResistanceMultidrug ResistanceResistance GenesAcinetobacter Baumannii InfectionAcinetobacter Baumannii ResistanceAminoglycoside AntibioticsAminoglycoside Resistance GenesCarbapenemase EnzymesEnzymesMultidrug-resistant OrganismsMultidrug-resistant Pathogens
The prevalence of aminoglycoside resistant enzymes has previously been reported and extended-spectrum β-lactamase among Acinetobacter baumannii. To track the risk of multidrug‑resistant A. baumannii, the present study aimed to determine the prevalence of carbapenemases in high‑level aminoglycoside resistant A. baumannii over two years. A total of 118 strains of A. baumannii were consecutively collected in the First Affiliated Hospital of Chengdu Medical College, Chengdu, China. These isolates were investigated on the genetic basis of their resistance to aminoglycosides. The results showed that 75 (63.56%) isolates were high‑level resistant to aminoglycosides, including gentamicin and amikacin (minimum inhibitory concentration, ≥256 µg/ml). Aminoglycoside‑resistant genes ant(2
49
Performance standards for antimicrobial susceptibility testing
Mary Jane Ferraro · 2001 · 9.8K citations
Dongeun Yong, Mark A. Toleman, Christian G. Giske et al. · Antimicrobial Agents and Chemotherapy · 2009 · 2.4K citations · Full text